中国药房2009，Vol.20Issue(29)：2249-2252,4.
长江流域6城市177家医院2004～2008年抗骨质疏松药利用分析
Utilization of Anti- osteoporosis Drugs in 177 Hospitals of 6 Cities along the Yangtze Valley During 2004～2008
郭虹 1徐领城2
作者信息
- 1. 浙江大学医学院附属第二医院药剂科,杭州市,310009
- 2. 浙江大学医学院附属第二医院药剂科,杭州市 310009
- 折叠
摘要
Abstract
OBJECTIVE: To probe into the status quo and the tendency of the utilization of the anti - osteoporosis drugs in hospitals along the Yangtze valley. METHODS: The utilization of the anti - osteoporosis drugs in 177 hospitals of 6 cities along the Yangtze valley during 2004-2008 was analyzed statistically in respect of the orders of consumption sum and defined daily dose (DDD) . RESULTS: The total amount of the drugs used for osteoporosis in the hospitals of the Yangtze valley showed year - on - year increase, and its proportion in the total remained at around 1.16% on the consumption sum list. The consumption sum of Diphosphonates showed sharp increase, many of its subcategories had forced into the top 10 places on the list of consumption sum and their rankings were moving forward steadily. Alfacalcidol and Calcitonin dominated the first two places over the 5 years. The top 10 manufacturers in terms of the sales sum of the drugs for osteoporosis were mainly foreign investment manufacturers and joint ventures. CONCLUSION: With the aging of the population and the strengthening of public awareness on health, the drugs used for osteoporosis enjoy a potential market, especially to domestic products and domestic manufacturers.关键词
骨质疏松/治疗药物/销售金额/限定日剂量/利用分析Key words
Osteoporosis/ Therapeutic drug/ Consumption sum/ Defined daily dose/ Analysis of utilization分类
医药卫生引用本文复制引用
郭虹,徐领城..长江流域6城市177家医院2004～2008年抗骨质疏松药利用分析[J].中国药房,2009,20(29):2249-2252,4.
